ITTN – Director
Dr. Yaron Daniely is the CEO and President of Yissum. Before joining Yissum in 2017, he served for eight years as President, CEO and Director of Alcobra Ltd. Prior to his appointment at Alcobra, Yaron was President and CEO of NanoCyte, Inc (2004-2007), based in Caesarea, Israel, where he focused on developing transdermal delivery technologies.
Previously, Yaron held a number of leadership positions, including General Manager and VP of Business Development at Gamida Cell-Teva Joint Venture, Ltd, a joint venture company based in Jerusalem, Israel which acquired an exclusive license to develop and commercialize a Phase 3-stage cell therapy product for treatment of Leukemia and Lymphoma. Additionally, he co-founded and served as Director of Bioblast Ltd. (NASADQ:ORPN).
Yaron earned a B.Sc. in Biological Sciences from Florida International University, and a PhD from the Sackler Institute of Graduate Biomedical Sciences at the NYU School of Medicine. Following his doctoral program, Yaron served as an NIH Visiting Fellow in its Cell Biology section and as a Postdoctoral Fellow in the Department of Molecular Cell Biology at The Weizmann Institute for Science in Israel. Subsequently, he received an Executive MBA from the Technion-Israel Institute of Technology.
Yaron co-founded Israel’s first M.B.A. program specializing in Biomedical Management at the College of Management Academic Studies (Rishon LeZion, Israel) and has served as the program’s director since its inception.
ITTN – Director
Gil Granot-Mayer holds an MBA degree from the Leon Recanati Graduate School of Business Administration and an LL.B. degree from Tel-Aviv University. Mr. Granot-Mayer was appointed as Yeda’s C.E.O in 2016 after having served as Deputy C.E.O and General Counsel of Yeda for 10 years. Prior to joining Yeda, Mr. Granot-Mayer worked in prominent law firms both as a commercial lawyer and as a litigator specializing in Intellectual Property, Cyberspace Law, E-commerce and Banking.
Mr. Granot-Mayer is a frequent speaker in various forums covering issues related to Intellectual Property, licensing and technology transfer.
Gil served in the Israeli Navy as a submarine crewmember during his extended military service.
Gil is married and has three children.
ITTN – Director
Dr. Luria received her PhD from the Weizmann Institute of Science, did her Post Doctorate at Stanford Medical School, and served as a visiting scientist at the Massachusetts Institute of Technology.
Dr. Luria has a unique combination of life science education, exhaustive research in cellular, molecular, genetic, immunology and virology fields coupled with extensive management and business experience in biomedical start-up companies.
Dr. Luria has expertise in fund-raising and fostering strategic partnerships with pharmaceutical and biotechnology companies worldwide and has demonstrated capabilities in developing biological products for the BioMedical companies.
Dr. Luria has comprehensive experience in biomedical technology assessment, due diligence, technical representation with strategic planning, management and development of biotechnology companies.
From 1999 to 2017, Dr. Luria has been involved in the establishment of more than 40 biomedical startup companies that raised over 260 Million USD in their seed stage.
From 2007 to Present – Dr. Luria serves as the Sheba Medical Center Technology Transfer Company Manager
• Raising Research Funds from Industrial resources to enhance Sheba's patent portfolio
• Commercialization of over 55% of the Sheba's IP portfolio - identification of potential partners, commercial and legal negotiation, preparing and executing licensing agreements with third parties.
• Managing Licensing Agreements and Inter Institutional Agreements.
• Board Member in Sheba's company spinoffs.
Tel: +972-3-5305998 Fax: +972-3-5305944 Cell: +972-052-6667277
ITTN - Director of IT
Tamir Huberman joined Yissum in 2004, he is the Chief Information Office (CIO). Tamir has developed the TTM, an IT system that is used by most of the TTO's in Israel.
In addition, he is also the IT Director at ITTN; the Israeli Technology Transfer Organization, a Director at InnerEye and Observer at BriefCam.
Prior to joining Yissum, Mr. Huberman was the Co-Founder of Artigon, served as part of the R&D team at Orgenics and as the Head of IP and R&D at MedisEl.
Tamir holds an MSc. in structural biology and a BSc. in biology from the Hebrew University, a diploma in computer & electronics and has continued his MBA studies at the Hebrew University. He is also a certified Trainer of NLP from ABNLP.
(LinkedIn Profile: http://il.linkedin.com/in/tamirhuberman/)